Original Articles · pages 337–343
Psychiatric Co-Morbidy and Quality of Life in Patients with Psoriasis in a Tertiary Care Hospital
Cite this article
Jwalant Chag, Archana Javadekar, Sudip Shankar Mukherjee, Suprakash Chaudhury, Daniel Saldanha. Psychiatric Co-Morbidy and Quality of Life in Patients with Psoriasis in a Tertiary Care Hospital. J Int Med Sci Acad. 2022;35(4):337–343.
Opening of the article
Background: Psoriasis is a chronic, dermatological disorder prone to relapses has adverse consequences on social, occupational, and other areas of functioning. Aim: To study the Psychiatric co-morbidity and social quality of life in psoriasis patients and compare them with controls. Method: This cross-sectional, case control study included 123 psoriasis patients and 123 matched healthy controls. All subjects were assessed with the Mini International Neuropsychiatric Interview, the Depression Anxiety Stress Scale, Psoriasis Life Stress Inventory (PLSI) and Psoriasis Area Severity Index (PASI). The data was analyzed using statistical software.
Keywords
Psoriasis, psychiatric morbidity, anxiety, depression, stress, quality of life 1Senior Resident, 2Professor, 3Jr Resident